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Comparison between intravenous and thoracic epidural
analgesia in single coronary artery bypass graft surgery
Nevriye SALMAN1, Fatih Tanzer SERTER2, Halil İbrahim UÇAR2, Serdar GÜNAYDIN3,
Ali Cem YORGANCIOĞLU2

Aim: To compare thoracic epidural analgesia with intravenous analgesia in patients who underwent coronary artery
bypass grafting surgery.
Materials and methods: This retrospective study included 40 patients who had received elective single artery bypass
surgery. After general anesthesia, one group was given patient-controlled thoracic epidural analgesia and the other
group was given patient-controlled intravenous meperidine analgesia. Patient assessments were performed during
the postoperative period and included the duration of hospital stay, pain and sedation scores, ambulation score, atrial
fibrillation incidence, and organ morbidities.
Results: No differences were detected between the groups in the demographic or intraoperative data. However, a
statistically significant difference was detected in favor of thoracic epidural analgesia for the duration of extubation and
hospital stay, pain control, sedation grade, mobilization, and quality of recovery scores.
Conclusion: After single coronary artery surgery, thoracic epidural analgesia was more effective than intravenous
analgesia; it also enabled earlier tracheal extubation and a shorter hospitalization period.
Key words: Coronary artery bypass grafting, analgesia, epidural, quality of recovery

Tekli coroner arter bypass greftleme cerrahisinde intravenöz ve torasik epidural
analjezinin karşılaştırılması
Amaç: Koroner arter bypass cerrahisinde, torasik epidural analjezinin intravenöz analjezi ile karşılaştırılmasıdır.
Yöntem ve gereç: Bu retrospektif çalışmada elektif tekli bypass cerrahisi yapılan 40 hasta iki grup halinde incelendi.
Genel anestezi sonrası bir gruba hasta kontrollü torasik epidural analjezi, diğer gruba ise hasta kontrollü intravenöz
meperidin analjezisi uygulandı. Postoperatif dönemde yapılan değerlendirmede hastanede yatış süresi, ağrı ve sedasyon
skorları, ambulasyon skoru, atrial fibrilasyon insidansı ve organ morbiditeleri incelendi.
Bulgular: İki grup arasında demografik ve intraoperatif veriler benzerdi. Ama, ekstübasyon zamanı, hastanede yatış
süresi, ağrı kontrolü, sedasyon derecesi, mobilizasyon ve derlenme kalitesi skorları açısından torasik epidural analjezi
lehine istatistiksel olarak anlamlı fark saptandı.
Sonuç: Tekli koroner arter cerrahisinden sonra analjezik açıdan torasik epidural analjezi intravenöz analjeziden daha
etkin bulundu. Ayrıca torasik epidural analjezi daha erken trakeal ekstübasyona ve daha kısa süreli hospitalizasyona
imkan verdi.
Anahtar sözcükler: Koroner arter bypass greftleme, analjezi, epidural, derlenme kalitesi
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Introduction
Numerous new surgical and anesthetic methods
have been developed in order to decrease the cost,
duration of hospital stay, and time off from work due
to major surgeries like coronary artery bypass grafting
(CABG). In recent years, studies found that the use
of thoracic epidural anesthesia or analgesia (TEA)
in CABG surgeries provided effective oxygen usage
and delivery balance in the ischemic myocardium by
selectively blocking cardiac sympathetic innervation
(thoracic nerves 1-5). This reduced the surgical
stress response, established hemodynamic stability,
reduced the incidence of new supraventricular
arrhythmias, and reduced myocardial ischemia (13). Thus, the use of TEA resulted in reduced infarct
rates during surgery in patients with ischemic heart
disease (4,5). In addition, TEA lowered the pain
score, enabled earlier extubation, and reduced the
incidence of complications, including respiratory
system infections, acute renal failure, and acute
confusion secondary to intravenous opioid usage
(6,7). Therefore, patients were permitted earlier
discharges (1-3,6,7). However, in some studies, TEA
did not provide any advantages in myocardial infarct
or mortality after CABG (8). Additionally, the choice
of TEA may be hindered by potential complications
in CABG patients, including epidural hematoma due
to heparinization, hemodilution, and a decrease in
coagulation factors.
In the present study, we studied patients who
had undergone general anesthesia and single CABG
surgery, and we compared the duration of hospital
stay, pain and sedation scores, ambulation score,
atrial fibrillation incidence, quality of recovery scores,
and organ morbidities between patient-controlled
thoracic epidural bupivacaine and intravenous
meperidine analgesia (IVA).
Materials and methods
After obtaining approval from the ethics committee,
we retrospectively evaluated the hospital records and
files of patients who underwent ASA II-III elective
on-pump single CABG surgery between February
2009 and April 2010. All of the patients received
general anesthesia followed by patient-controlled
analgesia. One group received TEA and the other
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received IVA. Patients were included if they were
under the age of 75 years, had received on-pump
CABG with an internal mammary artery graft by
median sternotomy, did not have any other cardiac
abnormality or did not undergo revision operation,
and had normal coagulation test values (e.g., partial
thromboplastin time of <45 s, prothrombin time of
<1.5, or platelet count of >80,000 cm–3). Exclusion
criteria were alcohol or other drug addiction,
contraindications for epidural anesthesia, systemic or
local infection, cervical and/or thoracic arthritis with
a neurological deficit, or a history of thrombolytic
or potent antithrombocytic drug use within 1
week prior to the procedure. The use of aspirin
was not considered a contraindication for epidural
anesthesia. Twenty patients who met the inclusion
criteria underwent TEA and another 20 matching
controls were chosen among the patients in whom
IVA was used as a routine application in our center.
A routine perioperative β-blocker was used for all of
the patients.
All of the patients received premedication of 10
mg of diazepam on the day before the operation and
0.05 mg kg–1 of intravenous midazolam on the day of
the operation. All of the patients were monitored with
electrocardiography, radial artery catheterization,
central venous pressure measurement via the internal
jugular vein, oximetry, urine output, capnography,
the bispectral index (BIS), and nasopharyngeal and
rectal temperature measurements.
Thoracic epidural catheterization was performed
2 h before surgery through the T4-5 or T56 interval
with a median approach and drop-hang technique,
with an 18-G Tuohy needle (Escopan + Docking
System + Perifix Soft Tip, B. Braun Melsungen AG,
Melsungen, Germany). The epidural catheter was
tested with 3 mL of 1% lidocaine. For all of the
patients, etomidate (0.2 mg kg–1), vecuronium (0.1
mg kg–1), and fentanyl (1 µg kg–1) were used for the
induction of anesthesia. Anesthesia was maintained
with isoflurane at a minimum alveolar concentration
of 1 (50% oxygen plus 50% air, and 0.5 µg kg–1 min–1
remifentanil infusion) after a bolus of 1 µg kg–1. The
depth of anesthesia was evaluated with the BIS. All
of the hemodynamic parameters of the patients
were recorded and intraoperative hypotension
was treated with dopamine; hypertension was
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treated with glyceryl trinitrate and additional drugs
(adrenaline, amiodarone, etc.), and pacemaker use
was recorded. A Dideco Evo oxygenator (Biodevices
Inc., Quezon City, the Philippines) was used during
the cardiopulmonary bypass after reaching the
activated clotting time of >400 s with heparin at
300 U kg–1. During the bypass, a prime solution
consisting of 1000 mL of Isolyte-S (Eczacıbaşı Baxter,
İstanbul, Turkey) and 500 mL of hydroxyethyl
starch (Voluven; Fresenius Kabi, Bad Hamburg,
Germany) was prepared, of which 700 mL was given
retrogradely and 800 mL remained for administration
in a nonpulsatile flow set of 2.41 L min–1 m–2. Mild
hypothermia (32-34 °C) was achieved, and cold
hyperkalemic cardioplegia was provided. The mean
arterial blood pressure was maintained between 50
and 90 mmHg in all of the patients during the bypass.
At the end of the bypass, heparin was antagonized by
the administration of protamine sulfate at 1 mg 100
U–1 of heparin. For patient-controlled TEA (Abbott
Pain Management Provider; Abbott Laboratories,
Chicago, IL, USA), a solution was prepared with
1.25 mg mL–1 bupivacaine and 2 µg.mL–1 fentanyl.
The locking duration was set to 20 min, the infusion
dose was 0.1 mL kg–1 h–1, the total dose lock range
for 24 h was 180 mL, and the loading dose was 0.1
mL kg–1. For patient-controlled IVA (Abbott Pain
Management Provider; Abbott Laboratories), a
solution was prepared with 5 mg mL–1 meperidine.
The locking duration was set to 10 min, the infusion
dose was 0.1 mL kg–1 h–1, the total dose lock range for
24 h was 600 mg, and the loading dose was 0.1 mL
kg–1. The patients in both of the groups were taken
to the intensive care unit after receiving the bolus
doses. Patient-controlled analgesia was begun and
continued for 3 days postoperatively. The patients
were sedated with a propofol infusion (5 mg kg–1
h–1) in the intensive care unit before extubation. An
oral dose of 500 mg of acetaminophen was given to
the patients 3 times daily for 3 days postoperatively.
Additional analgesic requirements were recorded.
When required, patients were given diclofenac
sodium at 75 mg intramuscularly as an additional
analgesic.
The extubation time was recorded in the intensive
care unit. Extubation criteria included (9): 1)
response to verbal orders; 2) body temperature above
36.5 °C; 3) drainage from chest tube of less than 100

mL h–1; 4) partial oxygen pressure over 70 mmHg or
inspired oxygen fraction of >0.5; 5) partial arterial
carbon dioxide pressure of less than 50 mmHg and
respiration count of less than 20 min–1 or pressureassisted ventilation under 10 cm H2O; and 6)
hemodynamic stability.
Patients were also evaluated with the quality of
recovery score (QoR-40) (8). Here, 5 parameters
were assessed, including physical comfort (12 items),
emotional status (9 items), physical independence (5
items), physiological support (7 items), and pain (7
items). QoR-40 scoring was performed preoperatively
and during the first 3 postoperative days.
Mobilization of the patients was attempted on
the first postoperative day. Mobilization scores
were recorded during the first 3 postoperative days
and were assessed (9) as follows: 0 = no movement;
1 = sitting on bed; 2 = standing up from bed; 3 =
walking 25 m; 4 = walking 50 m; 5 = walking 75 m;
6 = walking over 100 m; 7 = walking over 100 m and
climbing 1 flight of stairs; and 8 = walking over 100 m
and climbing 2 flights of stairs. Those with 6 or more
points were considered ambulatory.
The analgesic requirements of patients for the
first 3 postoperative days were assessed with the
visual analog scale (VAS), which ranged from 0 to 10
(10,11).
Sedation scoring was also conducted for the first
3 postoperative days. A 4-point sedation scale (12)
was utilized as follows: 0 = complete awareness; 1 =
mildly sedated (rarely asleep, but easily awakened);
2 = moderately sedated (usually asleep, but easily
awakened); and 3 = seriously sedated (somnolence,
difficult to awaken).
We also assessed the total duration of the hospital
stay. The criteria for discharge (9) included: 1)
hemodynamic stability without arrhythmia; 2)
easy mobility and ability to eat without help; 3) no
fever and or signs of infection; 4) normal urination
and defecation; 5) all meals taken orally; 6) pain
controlled with/without oral analgesics; 7) ability
to walk over 100 m and climb more than 2 flights of
stairs; and 8) normal mental status.
All of the parameters used in the comparisons
were extracted from the patients’ hospital data, which
were routinely recorded for all of the patients.
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All of the data were analyzed with SPSS 11.5
(SPSS Company, Chicago, IL, USA). The t-test was
used for comparing group means and the chi-square
or Fisher’s test was used to compare percentages. P <
0.05 was considered statistically significant.

significantly shorter (P = 0.008) for the TEA group
(6.5 ± 0.9 days) compared to the IVA group (7.6 ± 1.4
days) (Table 3).
The 2 groups were also significantly different
in their postoperative mobilization scores and
mobilization rates. The TEA group showed a more
rapid recovery of mobility in the first 3 postoperative
days (P = 0.001) (Figure 1).

Results
A total of 40 patients were eligible for inclusion in
the study. Twenty patients received thoracic epidural
bupivacaine analgesia (TEA group) and 20 received
intravenous meperidine (IVA group). The 2 groups
were not significantly different in demographics
(Table 1) or in intraoperative parameters (Table
2). Moreover, there were no significant differences
between the groups in postoperative parameters or
side effects (Table 3).

Preoperatively, there were no differences between
the groups (P = 0.338) in the QoR-40 scores. However,
during the first 3 postoperative days, the TEA group
had higher QoR-40 scores (day 1, P = 0.001; day 2, P
= 0.007; and day 3, P = 0.001) (Figure 2).
Based on the VAS pain scores, patients in the
TEA group experienced less pain during the first and
second days (P = 0.001 for both days), and there was
no significant difference between the groups on the
third day (P = 0.114) (Figure 3).

When the patients were compared with regard
to duration of intubation in the intensive care unit,
a statistically significant difference was detected
between the groups (P = 0.001). The TEA group was
intubated for an average of 9.0 ± 2.0 h and the IVA
group was intubated for an average of 12.4 ± 2.6 h.
Furthermore, the duration of the hospital stay was

Patients in the TEA group were significantly
less sedated compared to patients in the IVA group
during all 3 postoperative days based on sedation
scoring (days 1 and 2, P = 0.001; day 3, P = 0.036)
(Figure 4).

Table 1. Basic characteristics of the patients.
IVA* group
(n = 20)

TEA** group
(n = 20)

P

61.3 ± 10.2

58.8 ± 9.7

0.442

14/6

16/4

0.533

Weight (kg)

78.7 ± 13.5

81.4 ± 13.8

0.534

Height (cm)

166.0 ± 9.1

170.4 ± 7.5

0.106

Euro risk score

3.4 ± 2.7

2.8 ± 2.3

0.459

Left ventricular ejection fraction

59.4 ± 8.5

56.2 ± 12.5

0.360

Diabetes mellitus (%)

55

30

2.558

Hypertension (%)

65

40

2.506

Respiratory disorder (%)

0

5

1.000

Neurological disorder (%)

10

0

0.487

Smoking (%)

35

55

1.616

Alcohol use (%)

5

5

1.000

Age (years)
Sex (male/female)

*Intravenous analgesia
**Thoracic epidural analgesia
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Table 2. Intraoperative parameters.
IVA* group
(n = 20)

TEA** group
(n = 20)

P

Bypass duration (min)

37.6 ± 7.1

33.8 ± 8.1

0.124

Duration of aortic clamping (min)

20.8 ± 4.4

19.0 ± 4.6

0.214

Total remifentanil dose (mg)

7.08 ± 1.2

7.38 ± 1.2

0.462

Erythrocyte suspension (U)

1.05 ± 1.1

0.95 ± 1.2

0.796

Dopamine infusion (%)

0

15

0.231

Adrenaline infusion (%)

10

10

1.000

Glyceryl trinitrate infusion (%)

0

5

1.000

Amiodarone infusion (%)

0

0

-

Pacemaker usage (%)

5

0

1.000

IVA* group
(n = 20)

TEA** group
(n = 20)

P

12.4 ± 2.6

9.0 ± 2.0

0.001#

Nausea (%)

25

5

0.182

Vomiting (%)

5

0

1.000

Pruritus (%)

5

0

1.000

Atrial fibrillation (%)

15

15

1.000

Ventricular extrasystole (%)

0

5

1.000

Serum creatinine elevation (%)

10

0

0.487

New onset neurological deficit (%)

10

0

0.487

Permanent pacemaker (%)

5

0

1.000

7.6 ± 1.4

6.5 ± 0.9

0.008#

*Intravenous analgesia
**Thoracic epidural analgesia

Table 3. Postoperative parameters.

Duration of intubated period (h)

Duration of hospitalization (days)
*Intravenous analgesia
**Thoracic epidural analgesia
#
P < 0.05
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8

3.5

1st day
mobilization score
7

3.0

2nd day
mobilization score
3rd day
mobilization score

1st day VAS score
2nd day sedation score

2.5

3rd day VAS score
Mean score

6

Mean score

5

4

2.0

1.5

1.0

3

.5

2

0.0

IVA

IVA

Groups

TEAA

Figure 1. Mobilization scores during the first 3 postoperative
days (IVA: intravenous analgesia, TEA: thoracic
epidural analgesia).

1.4

1.2

190

1st day sedation score
2nd day sedation score

1.0

3rd day sedation score

Mean score

180

Mean score

TEAA

Figure 3. Pain scoring using VAS during the first 3 postoperative
days.

1

170

160

Preoperative
QoR-40 score
1st day
QoR-40 score

150

2nd day
QoR-40 score

.8

.6

.4

.2

3rd day
QoR-40 score

140
IVA

Groups

TEAA

Figure 2. QoR-40 quality of recovery scoring preoperatively and
during the first 3 postoperative days.

586

Groups

0.0

IVA

Groups

TEAA

Figure 4. Sedation scoring during the first 3 postoperative days.
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Discussion
In the past 20 years, TEA has been used more
frequently in CABG surgeries due to its advantages
in maintaining coronary blood flow, left ventricle
function, release of angina, hemodynamic stability,
stress hormone response, and respiratory function
(7). In contrast, Priestley et al. showed that TEA did
not shorten the duration of hospital stay, though
it was associated with earlier tracheal extubation
and better postoperative analgesia for patients who
underwent coronary artery surgery (7). Hansdottir et
al. also found that TEA did not shorten the duration
of hospital stay (9). Those results contrasted with
ours, possibly due to the anesthesia methods used and
surgical procedures applied; both can have an effect
on the duration of hospital stay. It is clear that many
studies have applied different surgical protocols and
different numbers of graft counts among the patients.
Different surgical methods and any additional
incision can also influence the duration of hospital
stay. In the present study, we attempted to compare
the effects of TEA and IVA in a more homogeneous
group by including only patients who received a
single on-pump CABG with an internal mammary
graft; thus, we excluded patients who received offpump CABG surgery or a saphenous vein graft and
patients with any other cardiac abnormalities.
The duration of immobilization is a particularly
crucial clinical parameter in the postoperative period.
Immobilization raises the risks of thromboembolism
and pulmonary complications. It also induces
orthostatic intolerance and instability upon standing.
In addition, it can cause losses in the quantity and
function of muscle tissues. Immobilization in the
supine position can delay wound healing by raising
hypoxemia due to negative effects on the cerebral
and cardiac systems (13,14). Thus, early, sufficient
mobilization in the postoperative period is vital.
In studies that used more effective multimodal
analgesia methods, including epidural analgesia
and opioids, patients had shorter immobilization
durations (14). In our study, the TEA group had better
mobilization scores than the IVA group during the
first 3 postoperative days. This result was associated
with early recovery, because the QoR-40 scores were
significantly higher in the TEA group than in the IVA
group during the first 3 postoperative days.

Various other studies have assessed postoperative
analgesic effects of TEA on patients administered
CABG. In a prospective, randomized study
conducted by Royse et al., TEA was associated
with lower pain scores compared to intravenous
morphine, both at rest and during coughing,
during the first 2 postoperative days (6). Priestly et
al. also found that TEA provided better analgesia
during resting and coughing compared to patientcontrolled intravenous morphine, but that was
limited to the first 24 h postoperatively (7). On the
other hand, in a study conducted by Hansdottir et al.,
TEA was not more effective on postoperative pain
control compared to patient-controlled intravenous
morphine in a similar patient group (9). However,
that study included patients who received multigraft
and nonstandardized surgical procedures, which
may have limited the efficacy of TEA. In our study,
patients on TEA showed better analgesia during
the first 48 h than patients on IVA, based on VAS
assessments.
Nausea and vomiting are among the most
frequent complaints that affect recovery in the
postoperative period. Numerous factors can induce
these symptoms; the most important, in connection
with anesthesiology, are the method of anesthesia and
the use of opioids. These symptoms can be prevented
or improved by using nonopioid local anesthetics
(14). In our study, there was no significant difference
between the 2 groups in terms of nausea and vomiting;
however, nausea and vomiting were encountered more
frequently in the TEA group. This may be attributed to
the low patient numbers in these groups; thus, we may
not have had sufficient power to adequately assess the
differences between the groups. Similar results were
obtained in evaluations of new neurological deficits,
including pruritus, agitation, and confusion.
Postoperative intubation durations are related
to confusion and sedation levels, and they are
closely associated with the method of anesthesia
and analgesia. In some studies, among patients who
received CABG, TEA provided a marked decrease in
the incidence of acute confusion; this may have been
secondary to a reduced need for opioids (3). A similar
effect was noted for sedation (7). In the present study,
we also detected markedly lower sedation scores in
the TEA group compared to the IVA group during the
587
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first 3 postoperative days; this contributed to earlier
extubation and earlier discharge from the hospital.
Contradictory results have been reported in studies
that examined perioperative TEA effects on the
incidence of postoperative atrial fibrillation. In some
studies, TEA administration during CABG reduced
the atrial fibrillation incidence by 50%. However, other
studies could not corroborate that effect (3,7). Jideus
et al. compared pre- and postoperative sympathetic
and parasympathetic activation, catecholamine
discharge, and heart rates among patients who did or
did not receive TEA. They demonstrated that TEA was
associated with depressed sympathetic activity and
markedly reduced epinephrine and norepinephrine
levels. In that study, the lower atrial fibrillation rates
observed in the TEA group were not associated with
statistically significant differences in the outcome
between the groups (15). In our study, no difference
could be detected in the postoperative atrial fibrillation
incidence between the groups. However, this could
have been due to the fact that, in our study, both groups
of patients received routine perioperative beta blockers
for the prevention of atrial fibrillation.

One of the most important considerations
regarding TEA application among patients
undergoing cardiac surgery is that anticoagulation
may lead to an increased risk of epidural hematoma,
which may result in spinal cord injury. However, these
complications are very rare (16,17). Only 1 out of 1528
patients who underwent a CABG experienced an
epidural hematoma secondary to catheterization that
resulted in spinal cord injury (16). Nevertheless, TEA
must be applied by experienced personnel, and great
attention must be given to the risks of heparinization,
hemodilution, and reduced coagulation factors
among patients undergoing cardiac surgery. In this
study, no catheter-related complications occurred in
the TEA group.
In conclusion, we found that in single coronary
artery bypass surgery, patient-controlled TEA
subsequent to general anesthesia was more beneficial
than IVA. TEA was associated with improved
postoperative pain control, earlier recovery and
mobilization, earlier extubation, and a shorter
hospital stay. We observed that this method can be
safely used in patients undergoing CABG.
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